Metabolites in Cancer

Oncogenomics is a sub field of genomics that portrays disease related qualities. It centers on genomic, epigenomic and transcript adjustments in growth. Malignancy is a hereditary malady caused by assemblage of DNA changes and epigenetic adjustments prompting uncontrolled cell multiplication and neoplasm advancement. The objective of oncogenomics is to recognize new oncogenes or tumor silencer qualities that may give new dreams into disease conclusion, expecting clinical aftereffect of developments and new focuses for malignancy treatments.

Cancer SocietiesChildren's Cancer AssociationFrench Society of Oncology PharmacyFrench Society of Oncology PharmacyBelgian Association of Oncological RadiotherapyCancer Registry BavariaEuropean Cancer Organization.

 

    Related Conference of Metabolites in Cancer

    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK
    March 24-25, 2025

    10th World Conference on Breast and Cervical Cancer

    Paris, France
    April 07-08, 2025

    15th World Congress on Breast Cancer

    Vancouver, Canada
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands
    July 14-15, 2025

    5th World Congress on Breast Cancer

    Berlin, Germany
    October 20-21, 2025

    21st International Conference on Cancer Research

    Barcelona, Spain

    Metabolites in Cancer Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in